Source: Proactive Investors

Genera Biosystems: Genera Biosystems enters potential company making partnership

Genera Biosystems Ltd (ASX:GBI) has been granted a trading halt this morning pending a co-marketing partnering agreement with a major IVD company in relation to its AmpaSand® molecular diagnostic testing menu. Genera is a molecular diagnostics company which develops, manufactures and distributes advanced PCR molecular diagnostics tests. The AmpaSand® testing platform can detect up to 125 target analytes in a single-well of a reaction plate. The halt will remain in place until the opening of trade on Wednesday 29th November 2017, or earlier if an announcement is made to the market.

Read full article »
Est. Annual Revenue
Est. Employees
CEO Avatar


Update CEO

CEO Approval Rating

- -/100